Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.11 USD | -1.14% | +14.57% | +39.84% |
24/05 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
24/05 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.84% | 2.49B | |
+17.69% | 3,289B | |
+14.62% | 90.43B | |
+14.59% | 85.57B | |
+37.27% | 52.49B | |
-20.56% | 50.25B | |
+32.93% | 46.79B | |
+83.75% | 42.74B | |
-32.70% | 41.67B | |
-1.24% | 27.82B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Transcript : Cellebrite DI Ltd., Q1 2024 Earnings Call, May 23, 2024